STOCK TITAN

Stoneridge (NYSE: SRI) director receives 23,478 restricted shares as equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Sklarsky Frank S reported acquisition or exercise transactions in this Form 4 filing.

STONERIDGE INC director Frank S. Sklarsky received a grant of 23,478 common shares as equity compensation. The shares were awarded at no cash cost to him under the company’s 2025 Long-Term Incentive Plan and increase his direct holdings to 75,357 common shares.

The granted shares are restricted stock that will remain subject to a substantial risk of forfeiture until March 16, 2027. This is a routine, non-market transaction reflecting stock-based compensation rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.

Insights

Director received routine restricted stock grant as long-term incentive.

Director Frank S. Sklarsky acquired 23,478 restricted common shares of STONERIDGE INC as a grant under the 2025 Long-Term Incentive Plan. The grant carried a transaction price of $0.0000 per share, indicating pure equity compensation rather than a market trade.

Following this award, his direct holdings rise to 75,357 common shares. The footnote states these restricted shares remain subject to substantial risk of forfeiture until March 16, 2027, aligning them with long-term performance and retention objectives. As a non-cash, compensation-related grant, it represents a routine governance practice rather than a directional market signal.

Insider Sklarsky Frank S
Role Director
Type Security Shares Price Value
Grant/Award Common Shares, without par value 23,478 $0.00 --
Holdings After Transaction: Common Shares, without par value — 75,357 shares (Direct)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sklarsky Frank S

(Last)(First)(Middle)
C/O STONERIDGE, INC.
39675 MACKENZIE DRIVE, SUITE 400

(Street)
NOVI MICHIGAN 48377

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
STONERIDGE INC [ SRI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares, without par value03/16/2026A23,478(1)A$075,357D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted Common Shares granted to the Reporting Person pursuant to the 2025 Long-Term Incentive Plan, no longer subject to substantial risk of forfeiture on March 16, 2027.
Remarks:
/s/ Robert M. Loesch, by power of attorney03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Stoneridge (SRI) director Frank S. Sklarsky report in this Form 4?

Director Frank S. Sklarsky reported receiving 23,478 restricted common shares of Stoneridge as an equity grant. The award was made at no cash cost under the 2025 Long-Term Incentive Plan and represents stock-based compensation rather than an open-market transaction.

How many Stoneridge (SRI) shares does Frank S. Sklarsky own after this grant?

After the reported grant, Frank S. Sklarsky directly holds 75,357 common shares of Stoneridge. This total includes the newly awarded 23,478 restricted shares, which expand his equity exposure as a director through the company’s long-term incentive program.

What type of transaction is reported for Stoneridge (SRI) in this Form 4?

The Form 4 reports an acquisition via grant of 23,478 restricted common shares to director Frank S. Sklarsky. It is coded as a grant or award transaction, not a market purchase or sale, and reflects stock-based compensation rather than trading activity in the open market.

When do Frank S. Sklarsky’s new Stoneridge (SRI) restricted shares vest or lose forfeiture risk?

The restricted common shares granted to Frank S. Sklarsky remain subject to substantial risk of forfeiture until March 16, 2027. This long vesting horizon aligns the grant with Stoneridge’s 2025 Long-Term Incentive Plan and is designed to support director retention and long-term performance alignment.

Was cash paid for the Stoneridge (SRI) shares reported in this Form 4?

No cash was paid for these shares; the transaction price per share is reported as $0.0000. The 23,478 common shares represent an equity grant to director Frank S. Sklarsky under Stoneridge’s 2025 Long-Term Incentive Plan, rather than an open-market purchase.